Opsonic and Antibody Responses to Pneumococcal Polysaccharide Types 6A, 19F and 23F after Vaccination of Immunocompromised Patients

References

• Amman A J, Addiego J, Wara D W, Lubin B, Smith W B, Mentzer W C. Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy. N Engl J Med 1977; 297: 897
   PubMed Web of Science ®Google Scholar
• Amman A J, Schiffman G, Addiego J E, Wara W M, Wara D W. Immunization of imunocompro-mised patients with pneumococcal polysaccharide vaccine. Rev Infect Dis 1981; 3: S160
   Google Scholar
• Austrian R, Douglas R M, Schiffman G, Coetzee A M, Koornhof H J, Hayden-Smith S, Reid R DW. Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians 1976; 89: 184
   PubMedGoogle Scholar
• Austrian R. Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev Infect Dis 1981; 3: SI
   Google Scholar
• Barret D J, Amman A J, Stenmark S, Wara D W. Immunoglobulin G and M antibodies to pneumococcal polysaccharides detected by enzyme-linked immunosorbent assay. Infect Immun 1980; 27: 411
   PubMed Web of Science ®Google Scholar
• Braconier J H, Odeberg H. Granulocyte phagocytosis and killing of virulent and avirulent serotypes of Streptococcus pneumoniae. J Lab Clin Med 1982; 100: 279
   PubMed Web of Science ®Google Scholar
• Brown E J, Hosea S W, Hammer C H, Burch C G, Frank M M. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bac-teriemia. J Clin Invest 1982; 69: 85
   PubMed Web of Science ®Google Scholar
• Broome C V. Efficacy of pneumococcal polysaccharide vaccines. Rev Infect Dis 1981; 3: S82
   PubMedGoogle Scholar
• Giebink G S, Foker J E, Kim Y, Schiffman G. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children. J Infect Dis 1980; 141: 404
   PubMed Web of Science ®Google Scholar
• Hilleman M R, Carlson A J, Jr, McLean A A, Vella P P, Weibel R E, Woodhour A F. Streptococcus pneumoniae polysaccharide vaccine: Age and dose responses, safety, persistence of antibody, revaccination and simultaneous administraton of pneumococcal and influenza vaccines. Rev Infect Dis 1981; 3: S31
   PubMedGoogle Scholar
• Hosea S W, Brown E J, Burch C G, Berg R A, Frank M M. Impaired immune response of splenectomized patients to polyvalent pneumococcal vaccine. Lancet 1981; 1: 803
   Web of Science ®Google Scholar
• Johansen K S, Karup Pedersen F. Antibody response and opsonization after pneumococcal vaccination in splenectomized children and healthy persons. Acta Pathol Microbiol Scand [C] 1982; 90: 205
   Google Scholar
• Karup Pedersen F, Henrichsen J. Detection of antibodies to pneumococcal capsular polysaccharides by enzyme-linked immunosorbent assay. J Clin Microbiol 1982; 15: 372
   PubMed Web of Science ®Google Scholar
• Karup Pedersen F, Henrichsen J, Schiffman G. Antibody response to vaccination with pneumococcal capsular polysaccharides in splenectomized children. Acta Paediatr Scand 1982; 71: 451
   PubMed Web of Science ®Google Scholar
• Karup Pedersen F. Antibody response to pneumococcal vaccine in splenectomized children. Acta Pathol Microbiol Scand [C] 1983; 91: 169
   PubMedGoogle Scholar
• Karup Pedersen F, Henrichsen J, Schiffman G. Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for detection of anti-pneumoccocal polysaccharide antibodies. Acta Pathol Microbiol Scand [C] 1983; 91: 251
   PubMedGoogle Scholar
• McCarty M. Pneumococci. Microbiology, B D Davis, R Dulbecco, H N Eisen, H S Ginsberg, W B Wood, M McCarty. Harper & Row, New York 1973; 694
   Google Scholar
• Minor D R, Schiffman G, McIntosh L S. Response of patients with Hodgkin's disease to pneumococcal vaccine. Ann Intern Med 1979; 90: 887
   PubMed Web of Science ®Google Scholar
• Nelson R D, Quie P G, Simmons R L. Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 1975; 115: 1650
   PubMed Web of Science ®Google Scholar
• Odeberg H, Olofsson T, Olsson I. Granulocyte function in chronic granulocytic leukemia. I. Bactericidal and metabolic capabilities during phagocytosis in isolated granulocytes. Br J Haematol 1975; 29: 427
   PubMed Web of Science ®Google Scholar
• Schmid G P, Smith R P, Baltch A L, Hall C A, Schiffman G. Antibody response to pneumococcal vaccine in patients with multiple myeloma. J Infect Dis 1981; 143: 590
   PubMed Web of Science ®Google Scholar
• Siber G R, Weitzman S A, Aisenberg A C, Weinstein H J, Schiffman G. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. N Engl J Med 1978; 299: 442
   PubMed Web of Science ®Google Scholar
• Siber G R, Weitzman S A, Aisenberg A C. Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens. Rev Infect Dis 1981; 3: S144
   Google Scholar
• Simberkoff M S, Schiffman G, Katz L A, Spicehandler J R, Moldover N H, Rahal J J, Jr. Pneumococcal capsular polysaccharide vaccination in adult chronic hemodialysis patients. J Lab Clin Med 1980; 96: 363
   PubMed Web of Science ®Google Scholar
• Smit P, Oberholzer D, Hayden-Smith S, Koornhof H J, Hilleman M R. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA 1977; 238: 2613
   PubMed Web of Science ®Google Scholar
• Wilkinson P C. Leukocyte locomotion and chemotaxis: Effects on bacteria and viruses. Rev Infect Dis 1980; 2: 293
   PubMedGoogle Scholar
• Winkelstein J A. Opsonins: their function, identity and clinical significance. J Pediatr 1973; 82: 747
   PubMed Web of Science ®Google Scholar